NASDAQ: SANA

Sana Biotechnology Inc Stock Forecast, Predictions & Price Target

The consensus among 2 Wall Street analysts covering (NASDAQ: SANA) stock is to Strong Buy SANA stock.

Out of 2 analysts, 1 (50%) are recommending SANA as a Strong Buy, 1 (50%) are recommending SANA as a Buy, 0 (0%) are recommending SANA as a Hold, 0 (0%) are recommending SANA as a Sell, and 0 (0%) are recommending SANA as a Strong Sell.

If you're new to stock investing, here's how to buy Sana Biotechnology stock.

(NASDAQ: SANA) Sana Biotechnology's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 1,251.4%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 29.08%.

Sana Biotechnology's revenue in 2023 is $0.On average, 1 Wall Street analysts forecast SANA's revenue for 2027 to be $3,646,964,348, with the lowest SANA revenue forecast at $3,646,964,348, and the highest SANA revenue forecast at $3,646,964,348. On average, 1 Wall Street analysts forecast SANA's revenue for 2028 to be $13,050,218,370, with the lowest SANA revenue forecast at $13,050,218,370, and the highest SANA revenue forecast at $13,050,218,370.

In 2029, SANA is forecast to generate $31,166,760,185 in revenue, with the lowest revenue forecast at $31,166,760,185 and the highest revenue forecast at $31,166,760,185.

According to 2 Wall Street analysts that have issued a 1 year SANA price target, the average SANA price target is $8.00, with the highest SANA stock price forecast at $8.00 and the lowest SANA stock price forecast at $8.00.

On average, Wall Street analysts predict that Sana Biotechnology's share price could reach $8.00 by Oct 12, 2024. The average Sana Biotechnology stock price prediction forecasts a potential upside of 88.68% from the current SANA share price of $4.24.

(NASDAQ: SANA) forecast ROE is -98.07%, which is considered weak.